Sotera Health Company announced a secondary offering of 20,000,000 shares of its common stock. All shares are being offered for sale by certain affiliates of Warburg Pincus LLC and GTCR LLC, who are identified as selling stockholders in the transaction.
The company itself is not offering any shares in this transaction and will not receive any proceeds from the sale. However, Sotera Health will be responsible for paying the expenses associated with the offering, as per its Amended and Restated Registration Rights Agreement.
Goldman Sachs & Co. LLC is acting as the underwriter for the offering. This type of offering, where existing shareholders sell a large block of shares, can increase the supply of stock in the market. The registration statement for these securities was filed with the SEC on February 27, 2024, and became effective automatically.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.